EU Okays Increase in mRNA COVID – 19 Vaccine Manufacturing Capacity

Paris / France – – Europe’s medicines regulator said on Tuesday it had approved additional manufacturing sites to increase production capacity of mRNA COVID-19 vaccines developed by Pfizer/BioNTech and Moderna for the region.

The recommendations do not require a decision by the European Commission and the sites can become operational immediately, the European Medicines Agency said.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s